The diverse functions of FAT1 in cancer progression: good, bad, or ugly?

ZG Chen, NF Saba, Y Teng - Journal of Experimental & Clinical Cancer …, 2022 - Springer
Abstract FAT atypical cadherin 1 (FAT1) is among the most frequently mutated genes in
many types of cancer. Its highest mutation rate is found in head and neck squamous cell …

Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations

W Zhang, Y Tang, Y Guo, Y Kong, F Shi… - NPJ Precision …, 2022 - nature.com
Immune checkpoint inhibitors (ICIs) are most commonly used for melanoma and non-small
cell lung cancer (NSCLC) patients. FAT atypical cadherin 1 (FAT1), which frequently mutates …

[HTML][HTML] Integrating genetic alterations and the Hippo Pathway in head and neck squamous cell carcinoma for future precision medicine

T Ando, K Okamoto, T Shintani, S Yanamoto… - Journal of Personalized …, 2022 - mdpi.com
Genetic alterations and dysregulation of signaling pathways are indispensable for the
initiation and progression of cancer. Understanding the genetic, molecular, and signaling …

Prognostic impact of caspase‐8 mutation in oral cavity squamous cell carcinoma

HJ Lu, CW Su, SC Su, LC Chang, MF Wu… - Oral …, 2024 - Wiley Online Library
Objective Identifying the drive genes and inhibiting their significant signals were persistently
the main concepts in cancer treatment. However, for oral cavity squamous cell carcinoma …

YAP-driven malignant reprogramming of oral epithelial stem cells at single cell resolution

F Faraji, SI Ramirez, LM Clubb, K Sato, V Burghi… - Nature …, 2025 - nature.com
Tumor initiation represents the first step in tumorigenesis during which normal progenitor
cells undergo cell fate transition to cancer. Capturing this process as it occurs in vivo …

SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment

E Snacel-Fazy, A Soubéran, M Grange, K Joseph… - Cell Death & …, 2024 - nature.com
Tumor-associated macrophages/microglia (TAMs) are highly plastic and heterogeneous
immune cells that can be immune-supportive or tumor-supportive depending of the …

Exploring the impact of GSTM1 as a novel molecular determinant of survival in head and neck cancer patients of African descent

F Yang, F Chen, C Shay, GZ Chen, NF Saba… - Journal of Experimental & …, 2024 - Springer
Abstract Background Blacks/African American (BAA) patients diagnosed with head and neck
squamous cell carcinoma (HNSCC) have worse survival outcomes than White patients …

[HTML][HTML] Genetic mutations associated with inflammatory response caused by HPV integration in oropharyngeal squamous cell carcinoma

M Atique, I Muniz, F Farshadi, M Hier, A Mlynarek… - Biomedicines, 2023 - mdpi.com
(1) Background: Head and neck cancer (HNC) ranks as the sixth most prevalent cancer in
the world. In addition to the traditional risk factors such as alcohol and tobacco consumption …

Identification of hub genes distinguishing subtypes in endometrial stromal sarcoma through comprehensive bioinformatics analysis

R Zhang, W Zhao, X Zhu, Y Liu, Q Ding, C Yang… - Scientific Reports, 2024 - nature.com
Diagnosing low-grade and high-grade endometrial stromal sarcoma (LG-ESS and HG-ESS)
is a challenge. This study aimed to identify biomarkers. 22 ESS cases were analyzed using …

[HTML][HTML] Phase II trial of CDX-3379 and cetuximab in recurrent/metastatic, HPV-negative, cetuximab-resistant head and neck cancer

JE Bauman, R Julian, NF Saba, TM Wise-Draper… - Cancers, 2022 - mdpi.com
Simple Summary This phase II, Simon 2-stage, multicenter study evaluated the efficacy of
the combination of CDX-3379 and cetuximab, monoclonal antibodies against ErbB3 and …